We are looking for babies with infantile spasms for a research study. Infantile spasms is a rare form of seizure disorder that presents within the first year of life. The purpose of this study is to find out more about the recovery of adrenal function after ACTH treatment for infantile spasms. Read More
Children with a diagnosis of infantile spasms.
Planned to receive treatment Acthar® (ACTH).
We are looking for adults with high blood pressure and/or high cholesterol for a research study. The purpose of the study is to test a behavioral weight control program improve weight loss, decision-making, and blood sugar levels. Read More
This study enrolls children with diagnosed with diabetic ketoacidosis (DKA) who will be admitted to the pediatric intensive care unit (PICU) for treatment. The purpose of this study is to compare the length of time patients have high acid in their blood and how long they have to stay in the hospital with DKA when they are treated with different types of IV fluids in the PICU. Read More
Children ages 0-18 years old.
Children who present with diabetic ketoacidosis and require pediatric intensive care unit admission.
The purpose of this study is to determine if better blood glucose control leads to improvement in neuropathy symptoms.This study involves questionnaires, physical exams and Sudoscan testing of palms and soles to assess nerve function. Read More
This study enrolls children with type 1 diabetes. The study medication is called tepluzimab and has been administered to over 450 children with new onset T1D in prior trials and has shown promising improvement of beta cell function. The purpose of this study is to find out a definitive answer regarding the ability of teplizumab to help children with newly diagnosed type 1 diabetes in preserving their own insulin production. Read More
Children ages 8-17 years (up to when a child turns 18) old who have been diagnosed with Type 1 diabetes in the last 6 weeks.
This study enrolls people who have participated in the preceding study, TrialNet Pathway to Prevention Study. The purpose of this study is to find out whether treatment of participants at Stage 1 Type 1 Diabetes with hydroxychloroquine delays progression to Stage 2 and Stage 3 Type 1 Diabetes. Please contact us to learn more about this research study. Read More
Children ages 3+ and adults.
Must have participated in preceding study (potential study participants will be identified through the ongoing TrialNet Pathway to Prevention Study).